SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $19.2M invested in Salarius Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.12M
2
+$301K
3
+$289K
4
Millennium Management
Millennium Management
New York
+$265K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$171K

Top Sellers

1
-$965K
2
-$612K
3
-$386K
4
SIM
Spark Investment Management
New York
-$223K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$211K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$38K
27
$17K
28
$13K
29
$13K
30
$6K
31
$3K
32
$1K
33
$1K
34
$27
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2